Tuesday, July 25 Time: 12:45 p.m. – 1:45 p.m. Location: Exhibit Hall Theater 1 Supported by Abbott
Myelodysplastic Syndrome (MDS) requires a complicated workup that can be supported by Artificial Intelligence (AI). Initial findings using AI have shown that MDS can be preliminarily identified with the data from an automated hematology analyzer.
Christy Thiessen, MPH, MT(ASCP) U.S. Marketing, Abbott Diagnostics
Christine Rongey, MD Medical Director, Abbott Diagnostics
Be the first to get all the latest news.